Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk today and set a price target of DKK475.00. Papadakis covers the He......

UBS analyst Matthew Weston maintained a Hold rating on Novo Nordisk today and set a price target of DKK295.00. According to TipRanks, Weston is a 4......

Novatti Group ( ($AU:NOV) ) has provided an update. Novatti Group Limited announced the quotation of 1,326,498 fully paid ordinary securities on th......

The obesity treatment space has been generating plenty of headlines – and sales – over the past few years. GLP-1 receptor agonists such as semaglut......

Enovis ( ($ENOV) ) has provided an update. On December 8, 2025, Enovis Corporation amended its existing credit agreement to enhance its financial f......

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk today and set a price target of DKK352.00. Quigley covers the Healthcar......

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novo Nordisk, with a price target of DKK295.00. Weston covers the H......

Morgan Stanley analyst Thibault Boutherin upgraded Novartis AG to a Buy today and set a price target of CHF115.00. Boutherin covers the Healthcare ......

Bank of America Securities analyst Sachin Jain reiterated a Hold rating on Novo Nordisk yesterday and set a price target of DKK340.00. The company’......

Novatti Group ( ($AU:NOV) ) just unveiled an announcement. Novatti Group Limited has announced a change in the interests of its director, Peter Paw......